EverSource Wealth Advisors LLC Grows Stake in SPDR S&P Biotech ETF $XBI

EverSource Wealth Advisors LLC lifted its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 478,533.3% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 28,718 shares of the exchange traded fund’s stock after buying an additional 28,712 shares during the period. EverSource Wealth Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $3,502,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also recently modified their holdings of XBI. Dynamic Wealth Strategies LLC lifted its position in SPDR S&P Biotech ETF by 3.8% during the fourth quarter. Dynamic Wealth Strategies LLC now owns 2,201 shares of the exchange traded fund’s stock valued at $268,000 after purchasing an additional 80 shares in the last quarter. Capital Investment Advisory Services LLC lifted its position in SPDR S&P Biotech ETF by 4.0% during the fourth quarter. Capital Investment Advisory Services LLC now owns 2,123 shares of the exchange traded fund’s stock valued at $259,000 after purchasing an additional 81 shares in the last quarter. Compass Ion Advisors LLC lifted its position in SPDR S&P Biotech ETF by 2.6% during the fourth quarter. Compass Ion Advisors LLC now owns 3,886 shares of the exchange traded fund’s stock valued at $474,000 after purchasing an additional 97 shares in the last quarter. Moors & Cabot Inc. lifted its position in SPDR S&P Biotech ETF by 3.8% during the third quarter. Moors & Cabot Inc. now owns 2,717 shares of the exchange traded fund’s stock valued at $272,000 after purchasing an additional 100 shares in the last quarter. Finally, Sequoia Financial Advisors LLC lifted its position in SPDR S&P Biotech ETF by 3.1% during the third quarter. Sequoia Financial Advisors LLC now owns 3,393 shares of the exchange traded fund’s stock valued at $340,000 after purchasing an additional 101 shares in the last quarter.

SPDR S&P Biotech ETF Stock Performance

NYSEARCA XBI opened at $131.66 on Friday. The business’s fifty day moving average is $129.82 and its 200 day moving average is $125.05. SPDR S&P Biotech ETF has a fifty-two week low of $78.00 and a fifty-two week high of $139.19. The company has a market capitalization of $8.40 billion, a PE ratio of 11.47 and a beta of 0.85.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.